ENDOLOGIX INC /DE/ — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

$143.4M

Net Income/Loss (FY2019)

-$64.8M

Total Assets (FY2019)

$307.2M

Total Equity (FY2019)

$63.9M

Cash Flows from Operating Activities (FY2019)

-$29.6M

Source: ENDOLOGIX INC /DE/ 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.